Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 30;2018(1):568-575.
doi: 10.1182/asheducation-2018.1.568.

Evidence-based management of immune thrombocytopenia: ASH guideline update

Cindy E Neunert  1 , Nichola Cooper  2
Affiliations
Review

Evidence-based management of immune thrombocytopenia: ASH guideline update

Cindy E Neunert et al. Hematology Am Soc Hematol Educ Program. .

Abstract

In 1996 and 2011, the American Society of Hematology (ASH) supported efforts to create guidelines for the diagnosis and management of patients with immune thrombocytopenia (ITP). These guidelines used different approaches to arrive at recommendations for testing and treatment. Despite differences in methodology, in both cases there was a paucity of randomized trials to inform recommendations. As data on the diagnosis and management of ITP expands, the ASH Committee on Quality is dedicated to maintaining updated guidelines representing recent evidence and guideline methodology. Here, we will review the updated ASH guidelines on ITP with a focus on recommendations with new understanding and future research to close knowledge gaps.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: N.C. is on the Board of Directors or an advisory committee for Amgen, has consulted for Novartis, has been affiliated with the Speakers Bureau for GSK and Amgen, has been a speaker at educational events organized by Novartis and Amgen, and participates in advisory boards for Amgen, and Novartis. C.E.N. declares no competing financial interests.

References

    1. George JN, Woolf SH, Raskob GE, et al. . Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3-40. - PubMed
    1. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190-4207. - PubMed
    1. Wei Y, Ji XB, Wang YW, et al. . High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016;127(3):296-302, quiz 370. - PubMed
    1. Mashhadi MA, Kaykhaei MA, Sepehri Z, Miri-Moghaddam E. Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia. Daru. 2012;20(1):7. - PMC - PubMed
    1. Praituan W, Rojnuckarin P. Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial. J Thromb Haemost. 2009;7(6):1036-1038. - PubMed

MeSH terms